You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
A股收評:滬指站上3600點,軍工、PEEK材料、銅纜高速連接大漲,醫藥下跌

今日,A股三大指數繼續上漲,滬指再次站上3600點。

截至收盤,滬指漲0.96%報3617點,深證成指漲0.59%,創業板指漲0.39%。

全天成交1.62萬億元,較前一交易日增量976億元,全市場超3900股上漲。

盤面上,PEEK材料爆發,新瀚新材、中欣氟材等多股漲停;消費電子板塊走高,福日電子、易德龍漲停;通信設備板塊走強,東信和平、長飛光纖等多股漲停;汽車零部件板塊活躍,新泉股份、湖南天雁及中馬傳動等多股漲停;銅纜高速連接、腦際接口、空間站概念及塑料製品等板塊漲幅居前。

另外,中藥板塊下挫,奇正藏藥跌停;Kimi概念走低,萬興科技領跌;重組蛋白、肝炎概念及化學制藥等跌幅居前。

具體來看:

軍工股漲幅居前,長城軍工4天3板,湖南天雁漲停,華強科技漲超8%,建設工業漲超4%。

PEEK材料走強,新瀚新材20CM漲停,華密新材漲超12%,中欣氟材、富春染織漲停,南京聚隆漲超9%,中研股份漲超8%,國恩股份、兄弟科技漲超6%,富恆新材漲超5%,凱盛新材漲超4%。

腦機接口板塊表現活躍,翔宇醫療漲超13%,創新醫療漲停,愛朋醫療、倍益康、榮泰健康漲超7%,普利特漲超5%。

高速銅纜連接板塊大漲,長芯博創漲超13%,奕東電子漲超10%,長飛光纖漲停,鑫科科技漲超8%,華脈科技漲超5%,兆龍互連、神宇股份漲超4%。

中藥板塊領跌,奇正藏藥跌停,新光藥業跌超8%,維康藥業跌超7%,貴州百靈、華森製藥、佛慈制藥、生物谷跌超6%,新天藥業、貴州三力跌超4%。

創新藥板塊回調,昂利康跌超9%,亞太藥業跌超8%,海特生物、舒泰神跌超7%,悅康藥業跌超5%。

影視院線板塊連續下跌,幸福藍海跌超6%,上海電影跌超5%,金逸影視、中國電影跌超2%。

AI智能體板塊走勢分化,普元信息跌超7%,卓易信息跌超6%,萬興科技跌超5%,鼎捷數智、焦點科技跌超4%,湖北廣電漲停,嘉和美康、思特奇漲超8%,楚天龍漲超7%,美格智能漲超6%。

展望未來,國金證券認爲,中國企業盈利改善的長期趨勢並沒有發生變化。美國二季度勞動力市場走弱爲美聯儲開啓降息提供了條件;而7月以來美國對外貿易環境趨於穩定,經濟領域邊際好轉的跡象已經出現,後續在美聯儲降息背景下海外製造業活動的修復同樣值得期待。

配置上,推薦如下:1)同時受益於海外製造業修復、國內“反內卷”政策推進的上遊資源品(銅、鋁,石油石化)及資本品(工程機械、重卡、叉車),中間品(鋼鐵)。2)未來股權將優於債權,保險的長期資產端將受益於資本回報的見底,建議關注非銀金融3)國內政策主線圍繞“民生”,建議關注紅利型消費(食品飲料、家電)以及部分服務業消費(酒店餐飲、旅遊休閒)。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account